These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4474120)

  • 21. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
    Hoak JC; Connor WE; Armstrong ML; Warner ED
    Lab Invest; 1968 Oct; 19(4):370-5. PubMed ID: 5699117
    [No Abstract]   [Full Text] [Related]  

  • 23. A kinetic comparison of the physiological effects of clofibrate and clofenapate in the rat.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(2):80-8. PubMed ID: 4459126
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on screening for cholesterol-lowering agents using phenyl- and chromane substituted compounds (author's transl)].
    Yoshida K; Nakamura H
    Hokkaido Igaku Zasshi; 1976 Nov; 51(6):513-8. PubMed ID: 1035574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of certain hypocholesterolemic agents on hepatic delta-aminolevulinic acid synthetase levels in mice.
    Weissman EB; Cheng LC; Orten JM
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):438-41. PubMed ID: 4814138
    [No Abstract]   [Full Text] [Related]  

  • 26. Interlobular differences in the changes induced in rat liver by clofibrate and clofenapate.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(5):243-50. PubMed ID: 4461276
    [No Abstract]   [Full Text] [Related]  

  • 27. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
    Stevens TJ; Stafford WW; Day CE; Block EM
    Artery; 1983; 12(2):81-94. PubMed ID: 6678582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbodies in experimentally altered cells. VII. CPID-induced hepatic microbody proliferation in the absence of significant catalase synthesis.
    Reddy J; Chiga M; Bunyaratvej S; Svoboda D
    J Cell Biol; 1970 Jan; 44(1):226-34. PubMed ID: 5409461
    [No Abstract]   [Full Text] [Related]  

  • 30. [Syntheses of new compounds with local anesthetic activity, IX:Syntheses of new phenyl benzyl ethers (author's transl)].
    Oelschläger H; Czasch HJ; Iglesias-Meier J; Ehlers E; Götze G
    Arch Pharm (Weinheim); 1978 Feb; 311(2):81-97. PubMed ID: 646593
    [No Abstract]   [Full Text] [Related]  

  • 31. Decrease in aldolase activity in the livers of clofenapate-treated rats.
    Ramasarma T; Ting SM; Horecker BL
    Indian J Biochem; 1971 Jun; 8(2):87-9. PubMed ID: 4259437
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Tomita T; Takeshita R; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
    [No Abstract]   [Full Text] [Related]  

  • 33. Amides of beta-(4-chlorophenoxy)-alpha-phenyl-ethylamines are inhibitors of cholesterol biosynthesis in vitro.
    Rossi S; Diamantini G; Pescador R
    Farmaco; 1989 Mar; 44(3):315-21. PubMed ID: 2775418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of hypolipidemic drugs. Introduction.
    Azarnoff DL
    Fed Proc; 1971; 30(3):827-8. PubMed ID: 5575294
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice.
    Périchon R; Bourre JM
    Biochem Mol Biol Int; 1995 Oct; 37(3):475-80. PubMed ID: 8595387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characterization of clofibrate-stimulated alkaline phosphatase in rat liver].
    Popova SV; Antonenkov VD; Panchenko LF
    Vopr Med Khim; 1983; 29(4):78-83. PubMed ID: 6623998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypolipidaemic agents (author's transl)].
    Tillement JP; Albengres E; Choisy H; Millart H
    Nouv Presse Med; 1980 Oct; 9(40):2947-50. PubMed ID: 7443428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rat hepatocyte peroxisomes: ultrastructural alterations following cessation of chronic dietary clofibrate administration.
    Hartman HA; Tousimis AJ
    Experientia; 1969 Dec; 25(12):1248-9. PubMed ID: 5365841
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of various hypocholesterolemic agents on human serum linoleate.
    Merrill JM
    Cardiovasc Res Cent Bull; 1968; 7(2):49-57. PubMed ID: 5743490
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of magnesium, potassium, antikaliuretic agents and hypocholesteremic agents in cardiac lesion development in rats fed a thrombogenic diet and Na 2 HPO 4 ].
    Savoie LL
    Pathol Biol (Paris); 1972 Oct; 20(19):751-6. PubMed ID: 4343433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.